Related by context. Frequent words. (Click for all words.) 69 NASDAQ CRXL 69 Inc Therapeutic Competitors 68 EntreMed Inc. 68 BioSpecifics Technologies Corp. 67 Nutra Pharma Corporation 67 Vitro Diagnostics 67 fibrosis IPF 67 Connetics Corporation 67 Exploit collaboration 66 SANUWAVE Health 66 MorphoSys AG FSE MOR 66 Fibrocell Science Inc. 66 Cerus Corporation 66 Regado Biosciences 66 Inc. Nasdaq NEXM 66 OSI Prosidion 66 Genaera Corporation 66 therapies Biogen Idec 65 Urigen Pharmaceuticals Inc. 65 Alseres Pharmaceuticals Inc. 65 Nanophase Technologies Corporation 65 addressing idiopathic pulmonary 65 LYON France BUSINESS WIRE 65 DIEST EDMONTON SUN 65 Idera Pharmaceuticals 65 ImmuneRegen BioSciences Inc. 65 By MICHAEL FORTUNA 65 BioMarin develops 65 DIEST SUN MEDIA 65 BY MICHAEL GELBWASSER 64 bpurser@macon.com 64 Crucell NV Euronext 64 Repligen Corporation 64 Inovio Pharmaceuticals 64 Adherex Technologies Inc. 64 Inc. OTCBB PWRM 64 Teleflex Incorporated 64 NASDAQ AEZS 64 Initiates Phase II 64 Bovie Medical Corporation 64 Announces FDA Clearance 64 Ceragenix Pharmaceuticals Inc. 64 Omeros Corporation 64 Senesco Technologies 64 pstrelow@thestate.com 64 High Growth Forecasted 64 Amgen discovers develops 64 BY JASON THOMPSON 64 Regulus Therapeutics 64 visit www.PAREXEL.com 63 Healthnostics Inc. 63 Introducing Leading Microcap 63 Barrier Therapeutics Inc. 63 China Aoxing Pharmaceutical 63 Inc. Nasdaq IMGN 63 By Neil Osterweil 63 BY DAVID LINTON 63 Company Nasdaq PRGO 63 Equipment Deals 63 Nasdaq ATEC 63 Transcept Pharmaceuticals 63 novel antibody therapeutics 63 Chemokine Therapeutics 63 Vicor Technologies 63 BY JIM HAND 63 bio therapeutics 63 BY STEPHANIE A. WILKEN 63 Colorado Coagulation Endocrine Sciences 63 commercializes biotherapeutics 63 FastMoneyTalk.com 63 By JAIME CONE 63 BY STEPHEN PETERSON 63 browland@nwherald.com 63 root = typeof 63 By OTIS R. 63 RHF Seven Summits Strategic 63 Mitteilung ist der Emittent 63 Anika Therapeutics 62 Adeona Pharmaceuticals Inc. 62 BY AMY DeMELIA 62 Medtech Insight division 62 BY MARK FARINELLA 62 Reportlinker Adds Global 62 Opexa Therapeutics Inc. 62 Pharmion Corporation 62 Fresenius Kabi AG 62 therapeutic monoclonal antibodies 62 Applied NeuroSolutions 62 By BOB AUDETTE 62 PINNACLEDIGEST.COM S PAST PERFORMANCE 62 Presents Positive 62 BY PETER GOBIS 62 BY WILLIAM ROLLER 62 IF WE DONT HAVE 62 CrossRef Web 62 LeMaitre Vascular Inc. 62 Pipeline Analysis 62 OMRIX 62 amassing #-# numbers 62 By FERMIN LEAL 62 ON SUCH DOW JONES